The cost utility of solifenacin in the treatment of overactive bladder

被引：0
|
作者：
Leona Hakkaart
Paul Verboom
Richard Phillips
Maiwenn J. Al
机构：
[1] Institute for Medical Technology Assessment,
[2] Erasmus MC,undefined
[3] Goffin Consultancy Ltd,undefined
来源：
International Urology and Nephrology | 2009年 / 41卷
关键词：
Urinary incontinence; Muscarinic receptor antagonist; Overactive bladder; Cost-utility analysis; Markov-model;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：293 / 298
页数：5
相关论文
共 50 条
  • [1] The cost utility of solifenacin in the treatment of overactive bladder
    Hakkaart, Leona
    Verboom, Paul
    Phillips, Richard
    Al, Maiwenn J.
    [J]. INTERNATIONAL UROLOGY AND NEPHROLOGY, 2009, 41 (02) : 293 - 298
  • [2] THE COST-UTILITY OF SOLIFENACIN IN THE TREATMENT OF PATIENTS WITH OVERACTIVE BLADDER IN CHINA
    Fan, C.
    Liao, L.
    Wang, J.
    Zhang, H.
    Chen, B.
    Wu, J.
    [J]. VALUE IN HEALTH, 2016, 19 (03) : A129 - A129
  • [3] Solifenacin - Treatment of overactive bladder
    Chilman-Blair, K
    [J]. DRUGS OF TODAY, 2004, 40 (04) : 343 - 353
  • [4] A cost-utility analysis of once daily solifenacin compared to tolterodine in the treatment of overactive bladder syndrome
    Speakman, Mark
    Khullar, Vik
    Mundy, Anthony
    Odeyemi, Isaac
    Bolodeoku, John
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (08) : 2173 - 2179
  • [5] Solifenacin succinate for the treatment of overactive bladder
    Hoffstetter, Susan
    Leong, Fah Che
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2009, 5 (03) : 345 - 350
  • [6] Solifenacin succinate for the treatment of symptoms of overactive bladder
    Maniscalco, Maria
    Singh-Franco, Devada
    Wolowich, William R.
    Torres-Colon, Rolando
    [J]. CLINICAL THERAPEUTICS, 2006, 28 (09) : 1247 - 1272
  • [7] COSTS OF OVERACTIVE BLADDER SYMPTOMS TREATMENT WITH SOLIFENACIN
    Avxentyeva, M.
    Gerasimova, K.
    Khachatryan, G. R.
    Frolov, M.
    Avxentyev, N. A.
    Pyadushkina, E.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A509 - A509
  • [8] Comparison of solifenacin and fesoterodine in treatment of overactive bladder
    Ercan, Onder
    Kostu, Bulent
    Bakacak, Murat
    Aytac-Tohma, Yusuf
    Coskun, Bora
    Avci, Fazil
    Efe, Erkan
    [J]. SAUDI MEDICAL JOURNAL, 2015, 36 (10) : 1181 - 1185
  • [9] The emerging role of solifenacin in the treatment of overactive bladder
    Robinson, D
    Cardozo, L
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2004, 13 (10) : 1339 - 1348
  • [10] Overactive bladder symptom score to evaluate efficacy of solifenacin for the treatment of overactive bladder symptoms
    Liu Ming
    Wang Jianye
    Yang Yong
    An Ruihua
    Wen Jianguo
    Guan Zhichen
    Zheng Shaobin
    Wang Dongwen
    Song Bo
    Liao Limin
    Guo Hongqian
    Xiao Jiaquan
    Sun Yinghao
    Shen Zhoujun
    Kong Chuize
    He Dalin
    Huang Yiran
    Wang Xiaofeng
    Zhang Xu
    Li Hanzhong
    Huang Jian
    Zhao Xiaokun
    Zeng Puqing
    Song Xishuang
    Ye Zhangqun
    [J]. 中华医学杂志(英文版), 2014, 127 (02) : 261 - 265
12345